Drugs / Evotaz®
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | Evotaz | — | 2015-07-13 | europa.eu ↗ |
| Approved | US (FDA) | EVOTAZ | — | 2015-01-29 | fda.gov ↗ |
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02697851 | Jul 2016 → Oct 2017 | HIV infectious disease | St Stephens Aids Trust | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Evotaz | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02697851 ↗ |